ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,029Medicare Part D Prescriptions Filled, Including Refills

Rank: 286 out of 2035

$550K Total Retail Price of All Prescriptions

Rank: 254 out of 2035

568 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 568 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 568 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 7,159 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 373 349 1 4
OMEPRAZOLE 290 272 2 5
SIMVASTATIN 289 267 3 1
AMLODIPINE BESYLATE 286 273 4 6
LISINOPRIL 251 232 5 3
PRAVASTATIN SODIUM 210 186 6 17
HYDROCODONE-ACETAMINOPHEN 208 152 S3 7 2
HYDROCHLOROTHIAZIDE 178 163 8 12
LOSARTAN POTASSIUM 172 156 9 15
ATENOLOL 155 143 10 10
FUROSEMIDE 154 149 11 7
ZOLPIDEM TARTRATE 134 130 12 21
ATORVASTATIN CALCIUM 128 113 13 13
LOVASTATIN 111 106 14 33
POTASSIUM CHLORIDE 103 95 15 18
TRAMADOL HCL 98 82 16 19
PREDNISONE 95 91 17 36
METFORMIN HCL 88 87 18 9
FENOFIBRATE 87 73 19 82
BENAZEPRIL HCL 86 84 20 128
CITALOPRAM HBR 86 72 20 20
FLUTICASONE PROPIONATE 81 71 22 29
DOXAZOSIN MESYLATE 81 74 22 111
METOPROLOL SUCCINATE 79 75 24 16
FINASTERIDE 78 78 25 105
METOPROLOL TARTRATE 74 73 26 8
CRESTOR 73 66 27 41
ALENDRONATE SODIUM 72 63 28 27
WARFARIN SODIUM 70 63 29 11
ESTRADIOL 60 55 R 30 293
DONEPEZIL HCL 58 57 31 24
SPIRONOLACTONE 55 49 32 65
CARVEDILOL 55 54 32 22
FELODIPINE ER 54 52 34 170
LANTUS SOLOSTAR 54 47 34 66
BETAMETHASONE DIPROPIONATE 52 43 36 246
VENLAFAXINE HCL ER 50 44 37 130
GABAPENTIN 50 39 37 14
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.